Jung M. Moon - Publications

CXCL5 is associated with neutrophil-driven intestinal inflammation and IL-17-associated epithelial signaling in inflammatory bowel disease.

Journal: Scientific reports

Published: February 03, 2026

Interpreting vedolizumab persistence: lessons from real-world trajectories in ulcerative colitis.

Journal: Intestinal research

Published: November 17, 2025

Combination Therapy with Oral Vancomycin Plus Intravenous Metronidazole Is Not Superior to Oral Vancomycin Alone for the Treatment of Severe Clostridioides difficile Infection: A KASID Multicenter Study.

Journal: Antibiotics (Basel, Switzerland)

Published: November 11, 2025

Role of miR-338-3p and miR-378a-3p as regulators in Crohn's disease pathogenesis: Potential therapeutic implications in inflammatory bowel disease.

Journal: Life sciences

Published: September 20, 2025

Clinical Approaches to Clostridioides difficile Infection Management: Insights From a Nationwide Survey of Korean Physicians.

Journal: Journal of Korean medical science

Published: April 27, 2025

Multiomics insights into functional constipation: Exploring microbiome, metabolome, and lipidome independent of transit time.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 24, 2025

Risk of avascular necrosis in patients with inflammatory bowel disease: Insights from a nationwide cohort study and the impact of corticosteroid use.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 07, 2024